Ilya Tsimafeyeu, Fuad Guliyev, Gunel Musayeva, Ramil Abdrakhmanov, Viacheslav Chubenko, Olga Baklanova, Ruslan Zukov, Vladislav Petkau, Igor Myslevtsev, Alisher Kahharov, Bakytzhan Ongarbayev, Dilyara Kaidarova. "Site-specific disease progression in patients with metastatic renal cell carcinoma treated with first-line nivolumab plus ipilimumab or axitinib-based immunotargeted combinations.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.478